
The entry of patients into zzso clinical trials zzso in lung cancer is zzso A study was undertaken to assess the reasons why patients with zzso cell lung cancer did not enter a trial involving zzso to receive or not receive three courses of zzso based chemotherapy in addition to primary treatment by surgery, zzso or best supportive zzso 

The study was carried out in two large London institutions with a special interest in recruiting patients to lung cancer zzso Patients recently diagnosed as having zzso cell lung cancer were zzso identified and followed to see whether they entered the zzso and, if not, to identify the main reasons zzso 

Six hundred and zzso eight patients newly diagnosed with zzso cell lung cancer were identified between November 1995 and July zzso zzso zzso were deemed ineligible for the zzso for clinical reasons, most frequently their general condition rendering them unfit for zzso Another 161 zzso were ineligible for logistical zzso example, they were discharged to zzso not participating in the zzso or they were not considered for the trial at an appropriate time in their zzso Of zzso potentially eligible patients, only 63 zzso of those zzso agreed to enter the zzso and four entered another zzso Of those who did not zzso 77 zzso declined without stating a reason, 61 zzso did not want chemotherapy, and only eight zzso expressed a wish to have zzso 

Despite considerable time and effort, the proportion of patients recruited was small zzso Many seen were ineligible but, of zzso potentially eligible patients, 186 zzso refused to enter the zzso 

